
AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own NexGen Energy today, you have to believe that the Rook I project can move from a capital intensive build into a long-life uranium producer, supported by regulatory approvals, community partnerships and ongoing exploration success at Patterson Corridor East. The surprise C$74.55 million profit in Q2 2026, after a heavy C$156.03 million loss in Q1, sharpens that story but does not yet rewrite it: the company still has no revenue, is loss making year to date and is not expected to be profitable in the near term. In the short run, the main catalysts remain construction progress at Rook I, further exploration results and any uranium offtake or financing updates, while key risks centre on cost overruns, further dilution and execution on a four year build-out. This quarter’s earnings beat strengthens confidence around cost control and financial flexibility, but investors will likely treat it as a supporting data point rather than a fundamental shift in the risk profile.
However, one key execution risk around funding and dilution is easy to miss at first glance. Our valuation report here indicates NexGen Energy may be overvalued.Explore 2 other fair value estimates on NexGen Energy - why the stock might be worth as much as 55% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com